Thomas Brida Biography and Net Worth

General Counsel of Invitae

Tom leads the legal and compliance team at Invitae. Tom has a broad-based legal background in the life science and diagnostic industries, having advised both public and private multinational companies on transactional and corporate matters. Prior to joining Invitae, Tom served as associate general counsel at Bio-Rad Laboratories and associate in Orrick's corporate and technology group. Tom holds a B.A. from Stanford University and a law degree from U.C. Berkeley School of Law.

What is Thomas Brida's net worth?: The estimated net worth of Thomas Brida is at least $193.13 as of August 16th, 2022. Mr. Brida owns 386,267 shares of Invitae stock worth more than $193 as of April 26th. This net worth approximation does not reflect any other assets that Mr. Brida may own. Additionally, Mr. Brida receives an annual salary of $776,720.00 as General Counsel at Invitae. Learn More about Thomas Brida's net worth.
How old is Thomas Brida?: Mr. Brida is currently 53 years old. There are 6 older executives and no younger executives at Invitae. The oldest executive at Invitae is Dr. Randal W. Scott Ph.D., Co-Founder & Chairman of the Board, who is 66 years old. Learn More on Thomas Brida's age.
What is Thomas Brida's salary?: As the General Counsel of Invitae Co., Mr. Brida earns $776,720.00 per year. The highest earning executive at Invitae is Mr. Kenneth D. Knight, President, CEO & Director, who commands a salary of $1,400,000.00 per year. Learn More on Thomas Brida's salary.
How do I contact Thomas Brida?: The corporate mailing address for Mr. Brida and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Thomas Brida's contact information.
Has Thomas Brida been buying or selling shares of Invitae?: Thomas Brida has not been actively trading shares of Invitae during the past quarter. Most recently, Thomas Brida sold 7,048 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $4.55, for a transaction totalling $32,068.40. Following the completion of the sale, the insider now directly owns 386,267 shares of the company's stock, valued at $1,757,514.85. Learn More on Thomas Brida's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.
Are insiders buying or selling shares of Invitae?: During the last year, insiders at the medical research company sold shares 5 times. They sold a total of 144,005 shares worth more than $208,408.56. The most recent insider tranaction occured on June, 13th when insider Robert L Nussbaum sold 7,086 shares worth more than $9,778.68. Insiders at Invitae own 0.7% of the company. Learn More about insider trades at Invitae.
Information on this page was last updated on 6/13/2023.

Thomas Brida Insider Trading History at Invitae

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/16/2022	Sell	7,048	$4.55	$32,068.40	386,267
5/17/2022	Sell	6,098	$3.81	$23,233.38	393,315
3/14/2022	Sell	17,987	$6.69	$120,333.03
8/16/2021	Sell	14,438	$25.42	$367,013.96
3/12/2021	Sell	16,051	$42.90	$688,587.90
11/17/2020	Sell	5,000	$46.01	$230,050.00
9/10/2020	Sell	633	$33.87	$21,439.71
8/19/2020	Sell	12,416	$32.10	$398,553.60
5/20/2020	Sell	2,060	$16.70	$34,402.00
3/16/2020	Sell	9,226	$11.79	$108,774.54	175,094
8/19/2019	Sell	13,663	$25.29	$345,537.27
5/20/2019	Sell	2,146	$18.21	$39,078.66
5/15/2018	Sell	1,979	$6.96	$13,773.84
2/16/2017	Sell	766	$9.69	$7,422.54	24,720
2/15/2017	Sell	794	$9.54	$7,574.76	26,280

Thomas Brida Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

$0.01

50 Day Range

MA: $0.01

$0.00

$0.02

2 Week Range

Now: $0.00

$0.02

Volume

271,771 shs

Average Volume

23,716,614 shs

Market Capitalization

$133,505.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Thomas Brida Biography and Net Worth

What is Thomas Brida's net worth?

How old is Thomas Brida?

What is Thomas Brida's salary?

How do I contact Thomas Brida?

Has Thomas Brida been buying or selling shares of Invitae?

Who are Invitae's active insiders?

Are insiders buying or selling shares of Invitae?